These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28928869)

  • 41. Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway.
    Weng MT; Tsao PN; Lin HL; Tung CC; Change MC; Chang YT; Wong JM; Wei SC
    PLoS One; 2015; 10(12):e0144322. PubMed ID: 26650241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer.
    Hu H; Wang M; Guan X; Yuan Z; Liu Z; Zou C; Wang G; Gao X; Wang X
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29371412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
    Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doublecotin-Like Kinase 1 Increases Chemoresistance of Colorectal Cancer Cells through the Anti-Apoptosis Pathway.
    Li L; Jones K; Mei H
    J Stem Cell Res Ther; 2019; 9(3):. PubMed ID: 31372308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells.
    Fukuyama R; Ng KP; Cicek M; Kelleher C; Niculaita R; Casey G; Sizemore N
    Mol Carcinog; 2007 May; 46(5):402-13. PubMed ID: 17186550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown on aPKC-ι inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.
    Du GS; Qiu Y; Wang WS; Peng K; Zhang ZC; Li XS; Xiao WD; Yang H
    Exp Mol Pathol; 2019 Apr; 107():57-67. PubMed ID: 30465755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis.
    Tong Q; Ouyang S; Chen R; Huang J; Guo L
    Am J Cancer Res; 2019; 9(9):1938-1956. PubMed ID: 31598396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
    Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Li J; Li X; Cen C; Ai X; Lin C; Hu G
    Oncol Rep; 2018 Jan; 39(1):217-226. PubMed ID: 29115526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
    Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
    Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
    Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
    [No Abstract]   [Full Text] [Related]  

  • 57. LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.
    Aggelou H; Chadla P; Nikou S; Karteri S; Maroulis I; Kalofonos HP; Papadaki H; Bravou V
    Virchows Arch; 2018 May; 472(5):727-737. PubMed ID: 29352327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
    Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
    Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells.
    Skarkova V; Kralova V; Krbal L; Matouskova P; Soukup J; Rudolf E
    Exp Cell Res; 2018 Aug; 369(2):295-303. PubMed ID: 29842879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal-epithelial reversion induced by γ-secretase inhibition.
    Dinicola S; Pasqualato A; Proietti S; Masiello MG; Palombo A; Coluccia P; Canipari R; Catizone A; Ricci G; Harrath AH; Alwasel SH; Cucina A; Bizzarri M
    Life Sci; 2016 Jan; 145():174-83. PubMed ID: 26746659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.